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Abstract
Staphylococcus (S.) aureus is an important cause of wound infections in companion animals, and infections with methicillin-
resistant S. aureus (MRSA) are of particular concern due to limited treatment options and their zoonotic potential. However,
comparable epidemiological data on MRSA infections in dogs, cats and horses is scarce, also limiting the knowledge about
possible links to MRSA isolates from human populations. To gain more knowledge about the occurrence and genotypic
variation of MRSA among wound swabs of companion animal origin in Germany we performed a survey (2010–2012)
including 5,229 samples from 1,170 veterinary practices. S. aureus was identified in 201 (5.8%) canine, 140 (12.2%) feline and
138 (22.8%) equine swabs from a total of 3,479 canine, 1,146 feline and 604 equine wounds, respectively. High MRSA rates
were identified with 62.7%, 46.4% and 41.3% in S. aureus of canine, feline and equine origin, respectively. Further
genotyping including spa typing and multilocus sequence typing (MLST) revealed a comparable distribution of spa types
among canine and feline MRSA with CC22 (47.6%; 49.2%) and CC5 (30.2%; 29.2%) as predominant lineages followed by
CC398 (13.5%; 7.7%) and CC8 (4.0%; 9.2%). In contrast, the majority of equine MRSA belonged to CC398 (87.7%). Our data
highlight the importance of S. aureus and MRSA as a cause of wound infections, particularly in cats and horses in Germany.
While ‘‘human-associated’’ MRSA lineages were most common in dogs and cats, a remarkable number of CC398-MRSA was
detected in horses, indicating a replacement of CC8-MRSA as the predominant lineage within horses in Germany. These
data enforce further longitudinal epidemiological approaches to examine the diversity and temporal relatedness of MRSA
populations in humans and animals to assess probable sources of MRSA infections. This would enable a sound risk
assessment and establishment of intervention strategies to limit the additional spread of MRSA.
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Introduction
Staphylococcus (S.) aureus is an important pathogen in human and
veterinary medicine that is capable of causing purulent and toxin-
mediated infections. An uptake of the mecA gene, which is encoded
on the Staphylococcal cassette chromosome mec, enables the
expression of an additional penicillin-binding protein (PBP)2a
which substitutes an essential cross-linking step of the native PBP2
in the presence of ß-lactams, leading to resistance against
antibiotics of this group [1]. In addition, methicillin-resistant S.
aureus (MRSA) are often resistant against further antimicrobial
classes [2].
MRSA raised attention in companion animal medicine during
the last decades, especially with regard to transmission from
humans to dogs and cats and vice versa [3–5]. Further, MRSA are
known as important nosocomial pathogens in both human and
veterinary medicine [6].
Data concerning the proportion and impact of S. aureus and
MRSA infections in clinical samples of companion animals are
variable but give evidence of an increased infection rate in horses
[7] as well as dogs and cats [8] during the last years. Wound
infections in particular are described to be frequently caused by S.
aureus [9,10].
Genotypic characterization of MRSA from several infection
sites of dogs and cats revealed the predominant occurrence of well-
known regional hospital associated (HA-) MRSA [5,11–13].
Within Germany, clonal complex (CC) 22-MRSA was reported
as the most common lineage in small animals in 2003 and 2004
[9,13]. Only recently, CC398-MRSA was reported as a cause of
canine infections in Germany, as well [14,15].
In contrast, CC8-MRSA were mainly identified in equine
infections, leading to suggestions of adaptation of this lineage to
horses [16]. In the recent past, studies revealed the occurrence of
LA-MRSA CC398 in horses, as well [7,16–18].
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Suspected transmission events between humans and small
animals or horses were reported several times in the past [3–
5,19] and strains of these lineages with the ability to infect different
hosts were denominated as Extended Host Spectrum Genotypes
(EHSGs) [17].
The predominance of infections with regularly occurring
regional human lineages in companion animals raised the question
whether dogs and cats might be an important source of human
infection and colonization [20]. Therefore, continuous S. aureus-
screening in specimens of companion animal origin with further
molecular characterization is important to determine changes in
frequency or possible adaptation of specific lineages to different
hosts.
Hence, we conducted a Germany-wide survey to investigate the
frequency of S. aureus among samples from clinical wound
infections of dog, cat and horse origin. The MRSA-proportion
was identified for S. aureus-positive samples. Each phenotypically
methicillin-resistant S. aureus was verified by PCR detection of
either the mecA or mecC gene and characterised by spa typing as
well as screening for the Panton-Valentine leukocidin (PVL).
Materials and Methods
Sampling and Case Definition
We included all swabs from dogs, cats and horses suffering from
wound infections, which were sent from 1,170 veterinarians within
Germany to Vet Med Labor GmbH (Ludwigsburg, Germany) for
bacteriological analysis between November 2010 and March 2012.
Vet Med Labor GmbH is one of the largest veterinary
microbiological laboratories, covering most areas within Germany.
The samples originated from either veterinarian clinicians or
practitioners working at mixed or specialized practices in 1,018
different areas with regard to the postal code throughout
Germany. TargetMap (www.targetmap.com) was used to visualize
the geographic origin of wound samples (figure 1). S. aureus positive
wound swabs were phenotypically investigated towards methicil-
lin-resistance based on susceptibility testing for oxacillin and
cefoxitin (VITEKH2, bioMe´rieux, Germany). All MRSA were sent
to the Institute of Microbiology and Epizootics, FU Berlin for
genotypic characterization.
Screening Procedure and Bacterial Characterization
All wound samples were streaked onto tryptic soy agar plates
supplemented with 5% sheep blood (Becton Dickinson, Heidel-
berg, Germany) and the plates were investigated after 24 and 48
hours. Colonies suspected to be staphylococci were identified using
the bioMe´rieux VITEKH2 system (Germany) according to the
manufacturers instructions. Automated antimicrobial susceptibility
testing of S. aureus was performed using the bioMerieux VITEKH2
system (Germany) according to the manufacturer’s instructions,
including penicillin, ampicillin-sulbactam, oxacillin, cefoxitin,
gentamicin, kanamycin, enrofloxacin, marbofloxacin, erythromy-
cin, clindamycin, tetracycline, nitrofurantoin, chloramphenicol
and trimethoprim- sulfamethoxazole, following the approved
standards of the Clinical and Laboratory Standards Institute
(CLSI) [21,22].
MRSA isolates were stored in glycerol stocks at 280uC at the
Institute of Microbiology and Epizootics (IMT). Species verifica-
tion and detection of the mecA or mecC gene by PCR was
performed for all MRSA as described before [23,24]. Further, 121
MRSA were characterized by spa typing [25]. Associations of spa
types with corresponding clonal complexes (CC) were determined
according to Ridom (http://spaserver.ridom.de/).
Multilocus sequence typing (MLST) was performed for one to
seven representatives of each detected spa type as described
elsewhere [26].
Detection of the genes encoding the Panton-Valentine leuko-
cidin (PVL)-factor was carried out as described before [27].
Results
Within a 17-month sampling period, veterinarians from 15
German Federal States sent 3,479 swabs declared as ‘‘wound
swabs’’ from dogs, 1,146 samples from cats and 604 samples from
horses to Vet Med Labor GmbH (Ludwigsburg, Germany)
(table 1). S. aureus was identified in 5.8% of canine, 12.2% of
feline and 22.8% of equine samples, respectively. MRSA
accounted for 62.7% of canine, 46.4% of feline and 41.3% of
equine S. aureus isolates. In total, 121 MRSA strains obtained from
dogs, 63 from cats and all isolates from horses were further
characterized by spa typing while five of the canine and two feline
MRSA were not available for the typing procedure. A detailed
Figure 1. Sample origin. Figure 1 shows the Germany-wide origin of the 5,229 wound swabs from dogs, cats and horses. Areas are shaped in color
with regard to the sample frequency. Black dots represent the sample origin with regard to the postal code. The dot size displays the submission
frequency of each veterinary practice/clinic.
doi:10.1371/journal.pone.0085656.g001
S. aureus in Wound Samples from Companion Animals
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overview of all detected spa types and corresponding CCs is given
in table 2. Most of the canine isolates belonged to clonal complexes
CC22 (47.6%; n= 60) and CC5 (30.2%; n= 38), followed by
CC398 (13.5%; n= 17), CC8 (4.0%; n= 5) and CC9 (0.8%; n= 1).
Comparable results were obtained for feline strains with CC22
(49.2%; n= 32), CC5 (29.2%; n= 19), CC398 (7.7%; n= 5) and
CC8 (9.2%; n= 6). In addition, a CC599-MRSA was identified in
one feline sample. The majority of MRSA isolates of equine origin
possessed spa types associated with CC398 (87.7%; n= 50). The
remaining equine isolates belonged to CC8 (8.8%; n= 5) as well as
CC5 and CC1 (each: one isolate) (figure 2).
MLST analysis, performed for at least one representative isolate
of each distinct spa type, revealed common sequence types (ST) for
isolates of CC1 (ST1), CC5 (ST5, ST225), CC8 (ST8, ST254),
CC9 (ST9) and CC398 (ST398). Representatives of CC22 showed
sequence types ST22, ST1117 as well as two new sequence types
(ST2743 and ST2745). The feline CC599-MRSA belonged to
ST599. All MRSA were mecA-positive except for the ST599-
MRSA, which yielded a positive signal for mecC [28]. Screening
Table 1. S. aureus proportion in wound samples from companion animals.
total % dog % cat % horse %
wound swabs 5,229 100 3,479 66.5 1,146 21.9 604 11.6
S. aureus 479 100 201 5.8 140 12.2 138 22.8
MSSA 231 48.2 75 2.2 75 6.5 81 13.4
MRSA 248 51.8 126 3.6 65 5.7 57 9.4
doi:10.1371/journal.pone.0085656.t001
Figure 2. Overview of lineage-diversity among MRSA from dogs, cats and horses.
doi:10.1371/journal.pone.0085656.g002
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for PVL revealed one positive canine CC8-MRSA (t008) as well as
one positive feline CC22-MRSA (t016).
Antimicrobial susceptibility testing was performed for all
MRSA. A detailed overview of all phenotypic resistance profiles
is given in table 3.
Discussion
This survey describes for the first time the Germany-wide
occurrence of MRSA and methicillin-susceptible S. aureus (MSSA)
in wound samples of companion animal origin. The considerable
high proportion of S. aureus-positive wound swabs from horses, cats
and dogs clearly shows the prominent clinical importance of this
pathogen in companion animal medicine. In view of MRSA being
a zoonotic pathogen, proportions of 9.4% (horses), 5.7% (cats) and
3.6% (dogs) among wound swabs are alarming and provide a
significant source for the spread in both veterinary clinics and the
community.
The genotypic characterization of MRSA in this study provides
comprehensive insights into the clonal background of MRSA in
wound infection samples of companion animal origin (figure 2)
and confirms the previous finding of CC22 and CC5 as
predominant lineages in dogs and cats [14,20] for Germany.
The predominance of these lineages in dogs and cats is in
accordance with findings in human medicine within Germany,
where most wound infections are caused by CC22- and CC5-
MRSA as well [29]. These findings lead to the suggestion that
humans might be a likely infection source for dogs and cats. In
addition, dogs and cats should be considered as (re-)infection and/
or colonization source for humans as well.
However, a recent study by Holden et al. demonstrated the
genetic changes that accompanied the emergence of EMRSA-15,
a typical hospital associated CC22-MRSA. A series of gene
acquisition events and mutations seemed to promote the success of
this clone in (human) hospitals. Accordingly, further comparative
genomic studies on MRSA obtained from veterinary and human
health care settings are warranted to evaluate factors influencing
success in veterinary environments (e.g. prescription of certain
antibiotics, acquisition of phages encoding virulence-enhancing
factors) [30].
Reports about LA-MRSA in pet animals [15,31,32] raised the
question whether these results represent incidental findings from
screening studies in companion animals [33]. As shown in this
study, the frequent finding of LA-MRSA CC398 among canine
and feline MRSA isolates demonstrates that CC398-MRSA is an
important lineage for canine and feline infections in Germany at
present. Further investigation is needed to determine whether this
genotype has the capacity to replace other common MRSA-
lineages in dogs and cats. However, the characterization of
different CC398 clades among humans in comparison to livestock
already demonstrated the adaptability of this genetic lineage [34].
Based on this knowledge and the regular appearance of CC398-
MRSA in pet animals, dogs and cats should be considered as a
potential source for human CC398-MRSA colonization and
infection, especially if contact to livestock or horses can be
excluded.
The CC398 proportion among equine MRSA identified in this
study is in concordance with previous reports of high CC398-
MRSA infection- and colonization rates in horses [7,18] and gives
evidence that MRSA of CC8 are almost completely replaced by
CC398 in equine wound infections within Germany. The
predominance of CC398-MRSA in wound swabs of horse origin
leads to the assumption that this lineage might have developed
some mechanisms for adaptation to the equine host.
Host adaptation has been described for several S. aureus-lineages
in the past. The emergence of a poultry-specific ST5-clade for
example was probably caused by a single human-to-poultry host
jump. Further acquisition of mobile genetic elements (MGE) from
avian specific lineages and the inactivation of several proteins with
importance in human infection led to the occurrence of a poultry-
specific clade [35]. Another example was given for CC97-S. aureus,
a lineage that has been predominantly identified in samples from
ruminants in the past. Only recently, CC97-MRSA were identified
as a cause of human infections as well. The emergence of two new
CC97 clones in the human population seems to be associated with
the acquisition of MGE which encode factors that enhance the
capacity to adapt to the human host [36].
In accordance with findings for CC5- and CC97-S. aureus,
different studies revealed the capacity of CC398 to adapt to
specific hosts including humans and livestock. The recent analysis
Table 2. Spa type frequency and predicted clonal complexes
based on spa typing and MLST for representative MRSA from
wound infections of canine, feline and equine origin in
Germany.
MRSA
CC spa type dog (n =121) cat (n =62) horse (57)
1 t127 0 0 1
5 t002 1 1 0
t003 31 17 1
t045 4 1 0
t1007 1 0 0
t264 1 0 0
8 t008 2 6 0
t009 1 0 4
t024 1 0 0
t12131 0 0 1
t036 1 0 0
9 t1430 1 0 0
22 t016 0 1 0
t020 0 4 0
t022 11 6 0
t032 43 17 0
t3846 0 1 0
t294 1 0 0
t557 1 0 0
t613 0 1 0
t1292 1 0 0
t747 2 0 0
t7982 0 2 0
t910 1 0 0
599 t278 0 1 0
398 t011 10 5 24
t034 2 0 0
t108 1 0 0
t6867 4 0 24
t10643 0 0 2
doi:10.1371/journal.pone.0085656.t002
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of 89 diverse CC398-S. aureus from Price et al. strongly suggests an
initial jump from humans to livestock, followed by adaptive
processes like the loss of phage-carried human-associated virulence
genes and the acquisition of tetracycline and methicillin resistance
[37]. Besides, a recent study showed the emergence of an animal-
independent ST398-MSSA with relevance in human infections in
northern Manhattan. In addition to a different subset of MGE,
these strains varied according to the set of intact adhesins, resulting
in enhanced adhesion to human keratinocytes and keratin and
demonstrated the adaptive capacity of ST398 strains to humans
[38]. Further investigation is required to see if CC398-MRSA of
equine origin harbour similar adaptive features.
Only one of the 243 MRSA yielded a positive signal for the
mecA-homologue mecC, indicating a sporadic occurrence of mecC-
MRSA in companion animals in Germany, as previously reported
[28]. A rather sporadic occurrence of PVL-carriage among
companion animal MRSA strains (two positives) is in accordance
with previous findings [39,40].
Phenotypic resistance profiles of all MRSA revealed a high
number of multi-resistant strains, in particular for CC5- and
CC398-MRSA, highlighting the limited therapeutic options to
treat most of these MRSA infections (table 3). Resistance profiles
from isolates of human origin associated with epidemic MRSA
lineages like CC22, CC5 and CC8 within German hospitals were
regularly reported by the national reference laboratory Robert
Koch-Institute (RKI) [29]. For ST22, the ‘‘Barnim epidemic
strain’’ (spa types t005, t002 and t032), resistance against
fluoroquinolones (ciprofloxacin, moxifloxacin) was frequently
observed. While care should be taken before comparing study
results (CC22-MRSA reported on here comprise more than these
three spa types), the frequent resistance (97.8%) against fluoro-
quinolones (enrofloxacin, marbofloxacin) is also present in CC22-
MRSA of companion animal origin. CC5-MRSA, human as well
as companion animal strains, seem to express resistance against
fluoroquinolones, clindamycin and erythromycin on a regular
basis. For CC8-MRSA, a diverse phenotypic resistance pattern
was observed. These results are in accordance with findings for
CC8-MRSA of human origin [41].
The study was biased to some degree due to inhomogeneity of
the case definition ‘‘wound infection’’ which was dependent on
veterinarians who sent their samples to Vet Med Labor GmbH
(Ludwigsburg, Germany). This survey focused on wound infec-
tions which have been sent to a diagnostic lab for microbiological
examination but does not take empirically treated wound
infections into account. Thus, calculated MRSA proportions
might not reflect the MRSA and MSSA rates in the general
companion animal population.
Another limitation is the lack of information for seven strains
(five canine and two feline MRSA), which were not available for
genotypic characterization.
Conclusion
This study provides evidence for the importance and impact of
S. aureus in general, and MRSA in particular, as a cause of wound
infections in dogs, cats and horses. The emergence of CC398-
MRSA as predominant genotype in equine wound infections
demonstrates the adaptive capacity of this lineage to other hosts
than livestock and humans. Since CC398-MRSA can be also
regularly identified in samples from dogs and cats, each of these
animals should be considered as potential infection and/or
colonization source for humans as well. Our findings clearly
demonstrate the need for on-going screening studies to gain
information about the replacement and emergence of certain
genetic lineages among these animals. Further investigation
including whole genome sequencing, phenotypic appearance and
functional studies are needed to unveil factors and structures
influencing the host adaptation processes like it has been
successfully demonstrated for adaptation of CC398 to humans
[38] and a CC5-clade to poultry [35]. Further attempts to reduce
the total burden of MRSA, in each field afflicted with this
pathogen, are clearly needed. Transmission of MRSA between
different hosts (humans, animals) as well as between different
ecological niches (hospital, community, veterinarian hospitals)
should be regarded as a major ‘‘One Health’’ problem.
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Table 3. Phenotypic resistance for 241 MRSA grouped according to their clonal complexes.
CC CC22 CC5 CC398 CC8 CC1 CC9 ST599
total number n=92 n=58 n=72 n=16 n=1 n=1 n=1
GEN 3 (3.3%) 2 (3.4%) 57 (79.2%) 7 (43.8%) 0 0 0
KAN 3 (3.3%) 35 (60.3%) 58 (80.6%) 14 (87.5%) 1 0 0
ENR 90 (97.8%) 57 (98.2%) 28 (38.9%) 14 (87.5%) 0 1 0
MAR 90 (97.8%) 57 (98.2%) 30 (41.7%) 14 (87.5%) 0 1 0
ERY 32 (34.8%) 57 (98.2%) 7 (9.7%) 3 (18.8%) 1 1 0
CLI 34 (37.0%) 57 (98.2%) 8 (11.1%) 2 (12.5%) 1 1 0
TET 7 (7.6%) 1 (1.7%) 68 (94.4%) 7 (43.8%) 1 1 0
NIT 0 0 0 2 (12.5%) 0 0 0
CHL 1 (1.1%) 0 0 0 0 0 0
SXT 1 (1.1%) 1 (1.7%) 25 (34.7%) 6 (37.5%) 0 1 0
Number (n) and percentage (%) of resistant strains according to VITEKH2 system (bioMe´rieux, Germany).
Abbreviations: GEN: gentamicin, KAN: kanamycin, ENR: enrofloxacin, MAR: marbofloxacin, ERY: erythromycin, CLI: clindamycin, TET: tetracycline, NIT: nitrofurantoin, CHL:
chloramphenicol and SXT: trimethoprim- sulfamethoxazole.
doi:10.1371/journal.pone.0085656.t003
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